skin and subcutaneous injury. Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention 1: first group: routine method of injection, subcutaneous anoxaparine (10 second duration injection technique). Intervention 2: second group: cold apply to injection site for 5 minute bef
Prevention
first group: routine method of injection, subcutaneous anoxaparine (10 second duration injection technique)
second group: cold apply to injection site for 5 minute before, 10 second injection duration
third group: 10 second injection duration and waiting 10 second before exit needle
fourth group: cold apply for 5 minute before 10 second injection duration and waiting 10 seconds before exit needle.
Sponsors
Golestan university of medical sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patient who receives subcutaneous injection of 60mg anoxaparine twice a day as treatment program; not to have coagulation disorders; not to have other injection in abdomen site; enable to express pain of injection; not to use analgesic medication four hours before injection; upper 18 and lower 65 years old; to have written approval. Exclusion criteria: patients who have abnormal coagulation; any change anoxaparine doses; have any other injections at the abdominal site except anoxaparine during the days of the research.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: immediately. Method of measurement: visual analog scale.;Skin bruise. Timepoint: 24, 48, and 72 hours later. Method of measurement: millimeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Rahmani anaraki
Golestan university of medical sciences
Outcome results
None listed